RE:RE:Pending news for HEXOThey may only report those consolodated numbers, but its also quite possible they report the pro-forma numbers of all three in another column. Personally I think the market understands that we own all enteties now and will extrapolate the numbers accordingly. Especially considering that they've already released the data for Redecan previously. The other two we're public so finding out those numbers isnt hard.
The true question will be how fast they can realize some of the synergies they've mentioned with the aquisitions. The sooner the better of course.
Jimmy713 wrote: Thanks Quinlash
Someone was saying Q4 will include only 2 months of Zenabis;
Q1 will include ALL Zenabis, and only 2 months of both 48NRTH and Redecan; Q2/2022 will be the one that includes All in all!
I personally couldn't understand it, my understanding as you below ... Do you see the rational of 2 months??? quinlash wrote: The two known news events that we can count are the followig
-> Oct 29th, 2021 - > 2021 Q4 / Year End QTR report which will include incremental sales from Zenabis Globale
-> Dec 15th, 2021 -> 2022 Q1 QTR report which will include incremental sales from 48 North and Redecan.
Both Dates are estimates with HEXO yet to confirm the exact date at this time.
Best Regards,
Q
- Long on HEXO